Jed Wiltzius

Director of External R & d @Lg Chem Life Sciences Usa, Inc

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2023 — Present

Director of External R & d @Lg Chem Life Sciences Usa, Inc

View department →

Cambridge, MA, US

EDUCATION

1997 — 2002

University of Wisconsin-Madison

B.S., Biochemistry

2004 — 2008

UCLA

Ph.D., Biochemistry and Molecular Biology

SKILLS

NextgenProtein ChemistryTarget IdentificationMonoclonal AntibodiesAssay DevelopmentAdcDrug DiscoveryExperimental DesignType 2 DiabetesCellCancerProtein ExpressionX-Ray CrystallographyMolecular BiologyProteomicsProtein CharacterizationOncologyBiotechnologyProtein PurificationManagerial ExperienceProtein EngineeringMelanomaAlzheimer's DiseaseAdccCell BiologyTechnological InnovationDna SequencingAntibodiesBiochemistry

ABOUT JED WILTZIUS

From ChatGPT)Jed Wiltzius is a scientist and researcher known for his contributions to immunotherapy and molecular biology, particularly in cancer research. He has been involved in developing chimeric antigen receptors (CARs) and antibody-based treatments for various cancers. Working with companies such as Kite Pharma and Amgen, Wiltzius has co-invented multiple patents focusing on engineered CAR T-cell therapies and antigen-binding molecules. These therapies, particularly aimed at targeting cancer cell markers like BCMA (used in multiple myeloma) and CD19 (used in B-cell malignancies), are pivotal in advancing precision medicine in oncology.His work has contributed to the development of technologies that enhance CAR T-cell functionality and specificity, improving therapeutic efficacy and reducing immune-related adverse effects, critical areas in the field of cellular therapy.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.